Schonfeld Strategic Advisors LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 114 filers reported holding INTERSECT ENT INC in Q3 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2020$2,750,000
+1027.0%
202,960
+884.4%
0.04%
+146.7%
Q1 2020$244,000
-63.0%
20,617
-22.2%
0.02%
-6.2%
Q4 2019$660,000
-17.6%
26,487
-43.8%
0.02%
-33.3%
Q3 2019$801,000
-66.5%
47,100
-55.1%
0.02%
-71.8%
Q2 2019$2,390,000105,0000.08%
Other shareholders
INTERSECT ENT INC shareholders Q3 2019
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders